J
Joseph S. Ross
Researcher at Yale University
Publications - 643
Citations - 22932
Joseph S. Ross is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & Clinical trial. The author has an hindex of 68, co-authored 565 publications receiving 19073 citations. Previous affiliations of Joseph S. Ross include Robert Wood Johnson Foundation & Dalhousie University.
Papers
More filters
Journal ArticleDOI
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
Reza Fazel,Harlan M. Krumholz,Yongfei Wang,Joseph S. Ross,Jersey Chen,Henry H. Ting,Nilay Shah,Khurram Nasir,Khurram Nasir,Andrew J. Einstein,Andrew J. Einstein,Brahmajee K. Nallamothu,Brahmajee K. Nallamothu +12 more
TL;DR: Imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation, which increased with advancing age and were higher in women than in men.
Journal ArticleDOI
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.
Kumar Dharmarajan,Angela F. Hsieh,Zhenqiu Lin,Héctor Bueno,Joseph S. Ross,Leora I. Horwitz,José Augusto Barreto-Filho,Nancy Kim,Susannah M. Bernheim,Lisa G. Suter,Elizabeth E. Drye,Harlan M. Krumholz +11 more
TL;DR: Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge.
Journal ArticleDOI
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.
Héctor Bueno,Joseph S. Ross,Yun Wang,Jersey Chen,María T. Vidán,Sharon-Lise T. Normand,Jeptha P. Curtis,Elizabeth E. Drye,Judith H. Lichtman,Patricia S. Keenan,Mikhail Kosiborod,Harlan M. Krumholz +11 more
TL;DR: For patients admitted with HF during the past 14 years, reductions in length of stay and in-hospital mortality, less marked reductions in 30-day mortality, and changes in discharge disposition accompanied by increases in30-day readmission rates were observed.
Journal ArticleDOI
An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure
Patricia S. Keenan,Sharon-Lise T. Normand,Zhenqiu Lin,Elizabeth E. Drye,Kanchana Bhat,Joseph S. Ross,Jeremiah D. Schuur,Brett D. Stauffer,Susannah M. Bernheim,Andrew J. Epstein,Yongfei Wang,Jeph Herrin,Jersey Chen,Jessica J. Federer,Jennifer A. Mattera,Yun Wang,Harlan M. Krumholz +16 more
TL;DR: This claims-based model of hospital risk-standardized readmission rates for heart failure patients produces estimates that may serve as surrogates for those derived from a medical record model.
Journal ArticleDOI
Recent National Trends in Readmission Rates After Heart Failure Hospitalization
Joseph S. Ross,Jersey Chen,Zhenqiu Lin,Héctor Bueno,Jeptha P. Curtis,Patricia S. Keenan,Sharon-Lise T. Normand,Geoffrey C. Schreiner,John A. Spertus,María T. Vidán,Yongfei Wang,Yun Wang,Harlan M. Krumholz +12 more
TL;DR: National mean and RSRR distributions among Medicare beneficiaries discharged after hospitalization for heart failure have not changed in recent years, indicating that there was neither improvement in hospital readmission rates nor in hospital variations in rates over this time period.